B64. Mechanistic Advances in Lung Fibrosis 2020
DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4037
|View full text |Cite
|
Sign up to set email alerts
|

Potential Clinical Utility of Serum KL-6 for Improving the GAP-Staging in Patients with Interstitial Lung Diseases (ILD)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles